SZSE:002581 (China)
Â
Class A
Â¥
9.9
+0.14 (+1.43%)
Mar 27
What is a stock summary page? Click here for an overview.
Business Description
Shandong Sinobioway Biomedicine Co Ltd
NAICS : 325998
SIC : 2899
ISIN : CNE1000012Y5
Share Class Description:
SZSE:002581: Class ACompare
Compare
Traded in other countries / regions
002581.China IPO Date
2011-05-20Description
Shandong Sinobioway Biomedicine Co Ltd is engaged in the research, development, manufacturing and marketing of trimethyl orthoformate and triethyl orthoformate.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2051.9 | |||||
| Equity-to-Asset | 0.91 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 43.07 | |||||
| Beneish M-Score | -2.93 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15.7 | |||||
| 3-Year EBITDA Growth Rate | -26.1 | |||||
| 3-Year EPS without NRI Growth Rate | -20.5 | |||||
| 3-Year FCF Growth Rate | 6.1 | |||||
| 3-Year Book Growth Rate | -1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.38 | |||||
| 9-Day RSI | 51.26 | |||||
| 14-Day RSI | 47.49 | |||||
| 3-1 Month Momentum % | -9.54 | |||||
| 6-1 Month Momentum % | 0.41 | |||||
| 12-1 Month Momentum % | -8.96 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.18 | |||||
| Quick Ratio | 9.93 | |||||
| Cash Ratio | 6.64 | |||||
| Days Inventory | 375.87 | |||||
| Days Sales Outstanding | 120.41 | |||||
| Days Payable | 203.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 2.15 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 79.85 | |||||
| Operating Margin % | -30.18 | |||||
| Net Margin % | -85.57 | |||||
| FCF Margin % | -16.08 | |||||
| ROE % | -16.3 | |||||
| ROA % | -14.53 | |||||
| ROIC % | -6.31 | |||||
| 3-Year ROIIC % | -181.07 | |||||
| ROC (Joel Greenblatt) % | -49.24 | |||||
| ROCE % | -11.49 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 55 | |||||
| PS Ratio | 16.04 | |||||
| PB Ratio | 3.12 | |||||
| Price-to-Tangible-Book | 3.29 | |||||
| EV-to-EBIT | -23.51 | |||||
| EV-to-EBITDA | -23.51 | |||||
| EV-to-Revenue | 15.08 | |||||
| EV-to-FCF | -93.78 | |||||
| Price-to-GF-Value | 0.53 | |||||
| Price-to-Projected-FCF | 5.47 | |||||
| Price-to-Median-PS-Value | 1.05 | |||||
| Price-to-Net-Current-Asset-Value | 12.69 | |||||
| Price-to-Net-Cash | 29.12 | |||||
| Earnings Yield (Greenblatt) % | -4.25 | |||||
| FCF Yield % | -1 | |||||
| Forward Rate of Return (Yacktman) % | 9.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Sinobioway Biomedicine Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 406.154 | ||
| EPS (TTM) (Â¥) | -0.527 | ||
| Beta | 1.14 | ||
| 3-Year Sharpe Ratio | -0.49 | ||
| 3-Year Sortino Ratio | -0.66 | ||
| Volatility % | 46.25 | ||
| 14-Day RSI | 47.49 | ||
| 14-Day ATR (Â¥) | 0.269672 | ||
| 20-Day SMA (Â¥) | 9.9065 | ||
| 12-1 Month Momentum % | -8.96 | ||
| 52-Week Range (Â¥) | 7.79 - 14.43 | ||
| Shares Outstanding (Mil) | 659.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shandong Sinobioway Biomedicine Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shandong Sinobioway Biomedicine Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shandong Sinobioway Biomedicine Co Ltd Frequently Asked Questions
What is Shandong Sinobioway Biomedicine Co Ltd(SZSE:002581)'s stock price today?
The current price of SZSE:002581 is ¥9.90. The 52 week high of SZSE:002581 is ¥14.43 and 52 week low is ¥7.79.
When is next earnings date of Shandong Sinobioway Biomedicine Co Ltd(SZSE:002581)?
The next earnings date of Shandong Sinobioway Biomedicine Co Ltd(SZSE:002581) is .
Does Shandong Sinobioway Biomedicine Co Ltd(SZSE:002581) pay dividends? If so, how much?
Shandong Sinobioway Biomedicine Co Ltd(SZSE:002581) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers